Biovie (BIVI) Change in Cash (2013 - 2026)
Biovie (BIVI) posted Change in Cash of -$7.4 million for Q1 2026, down 67.69% sequentially from -$4.4 million in Q4 2025, and down 493.67% YoY from $1.9 million in Q1 2025.
Biovie (BIVI) Change in Cash (2013 - 2026) Analysis & Trends
Biovie has reported Change in Cash for 14 years, with the latest figure at -$7.4 million in Q1 2026.
- Quarterly Change in Cash fell 493.67% year-over-year to -$7.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$10.1 million (down 39.66% YoY) and the FY2025 annual result came in at -$6.3 million, down 243.72% from the prior year.
- Change in Cash eased to -$7.4 million in Q1 2026 per BIVI's latest filing, from -$4.4 million in the prior quarter.
- Over five years, Change in Cash peaked at $24.5 million in Q4 2022 and troughed at -$14.5 million in Q1 2023.
- A 5-year average of $6662.9 and a median of -$3.8 million in 2024 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2022 and 2024: Change in Cash tumbled 1021.01% in 2022, then jumped 543.55% in 2024.
- Over 5 years, Change in Cash stood at $24.5 million in 2022, then plunged by 104.03% to -$987972.0 in 2023, then surged by 543.55% to $4.4 million in 2024, then sank by 201.27% to -$4.4 million in 2025, then slumped by 67.69% to -$7.4 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered -$7.4 million, -$4.4 million, and $7.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Biovie | 14.17 Mn | 14.17 Mn | - | -4.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.12 Mn |
| Mar 31, 2026 | -7.44 Mn |
| Dec 31, 2025 | -4.44 Mn |
| Sep 30, 2025 | 7.43 Mn |
| Jun 30, 2025 | -5.61 Mn |
| Mar 31, 2025 | -1.25 Mn |
| Dec 31, 2024 | 4.38 Mn |
| Sep 30, 2024 | -3.82 Mn |
| Jun 30, 2024 | -6.51 Mn |
| Mar 31, 2024 | 10.12 Mn |
| Dec 31, 2023 | -987,972.00 |
| Sep 30, 2023 | 1.75 Mn |
| Jun 30, 2023 | -11.82 Mn |
| Mar 31, 2023 | -14.47 Mn |
| Dec 31, 2022 | 24.52 Mn |
| Sep 30, 2022 | 20.00 Mn |
| Jun 30, 2022 | -5.87 Mn |
| Mar 31, 2022 | -5.88 Mn |
| Dec 31, 2021 | 9.90 Mn |
| Sep 30, 2021 | 15.98 Mn |